Outcomes of Surgically Ineligible Patients With Multivessel CAD

Active, not recruitingOBSERVATIONAL
Enrollment

750

Participants

Timeline

Start Date

December 15, 2016

Primary Completion Date

June 30, 2020

Study Completion Date

July 31, 2025

Conditions
Coronary Artery Disease
Trial Locations (21)

10032

Columiba University Medical Center, New York

11030

Northwell Health System, Manhasset

15213

University of Pittsburgh Medical Center, Pittsburgh

17822

Geisinger Health System, Danville

20010

Washington Hospital Center, Washington D.C.

22908

University of Virginia Medical Center, Charlottesville

25304

Charleston Area Medical Center, Charleston

30308

Emory University Hospital Midtown, Atlanta

30606

Piedmont Heart Institute, Atlanta

44106

University Hospitals Cleveland Medical Center, Cleveland

44195

Cleveland Clinic, Cleveland

48202

Henry Ford Hospital, Detroit

55905

Mayo Clinic, Rochester

63110

Washington University in Saint Louis, St Louis

64111

Saint Luke's Hospital of Kansas City, Kansas City

66160

University of Kansas Medical Center, Kansas City

85006

Banner University Medical Center, Phoenix

92037

Unifersity of California San Diego Medical Center, San Diego

98195

University of Washington Medical Center, Seattle

02114

Massachusetts General Hospital, Boston

02215

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
collaborator

Piedmont Heart Institute, Inc., Atlanta, GA

INDUSTRY

lead

Saint Luke's Health System

OTHER

NCT02996877 - Outcomes of Surgically Ineligible Patients With Multivessel CAD | Biotech Hunter | Biotech Hunter